PANDAS is best described as an autoimmune condition, though its exact classification remains a point of debate in the medical community. The leading theory is that a strep infection triggers an immune response that mistakenly attacks part of the brain, causing sudden psychiatric and neurological symptoms in children. While researchers and clinicians widely treat it as autoimmune in nature, PANDAS does not appear in major diagnostic manuals like the DSM-5 or the ICD-11 as a formally defined disorder with operational diagnostic criteria.
How the Autoimmune Mechanism Works
The proposed cause of PANDAS follows a well-known immunological pattern called molecular mimicry. When a child gets a strep throat infection, their immune system produces antibodies to fight the streptococcal bacteria. In children with PANDAS, those antibodies also cross-react with proteins in the brain, particularly in a region called the basal ganglia, which helps regulate movement, emotions, and habits.
In other words, the immune system confuses brain tissue for the infection it’s trying to fight. This is the same basic mechanism behind other recognized autoimmune conditions, like rheumatic fever, where strep antibodies attack the heart. With PANDAS, the target is the brain instead. Research has found accumulating evidence that autoantibodies target antigens in the basal ganglia, though results across studies have been mixed, which is one reason the condition remains somewhat controversial.
Why the Classification Is Still Debated
Despite strong theoretical grounding and clinical observations spanning decades, PANDAS occupies an unusual place in medicine. It is not listed in the DSM-5, the primary handbook for diagnosing mental disorders in the United States and much of the world. The ICD-11 mentions PANDAS but does not define operational diagnostic criteria for it. A consensus statement from the British Paediatric Neurology Association confirmed both of these gaps.
This doesn’t mean the condition isn’t real. It means the medical community hasn’t reached full agreement on exactly where it fits, how to diagnose it reliably, or how to separate it from other causes of sudden-onset psychiatric symptoms in children. Some clinicians and researchers view it as a distinct autoimmune encephalitis (inflammation of the brain driven by the immune system), while others argue the evidence isn’t strong enough to distinguish it from other childhood neuropsychiatric conditions. The National Institute of Mental Health considers PANDAS rare but actively discusses it alongside the broader category of PANS.
PANDAS vs. PANS
PANDAS stands for Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections. The word “autoimmune” is built into the name itself, reflecting the hypothesis that drove its original description. PANS, or Pediatric Acute-onset Neuropsychiatric Syndrome, is a broader category that covers similar sudden-onset symptoms but doesn’t require strep as the trigger. PANS can follow other infections, metabolic disturbances, or environmental factors.
Both conditions typically first appear between age 3 and puberty, and both are considered rare, though exact prevalence numbers are unknown. PANDAS is essentially a subset of PANS where the trigger has been identified as a strep infection.
What the Symptoms Look Like
The hallmark of PANDAS is a dramatic, sudden onset of OCD symptoms or tics in a child, often seemingly overnight. A child who was functioning normally might suddenly develop intense obsessive thoughts, compulsive rituals, or involuntary movements. Parents frequently describe the change as being like a light switch flipping.
Beyond OCD and tics, children may experience severe anxiety, emotional outbursts, regression in behavior (such as baby talk or bedwetting in an older child), difficulty with handwriting or other fine motor skills, trouble sleeping, and changes in eating. The symptoms often flare and subside in episodes, sometimes worsening with each new strep infection. This episodic, relapsing pattern tied to infections is one of the features that distinguishes PANDAS from typical childhood OCD or tic disorders.
How PANDAS Is Treated
Because PANDAS is understood as immune-driven, treatment targets both the infection and the immune response, not just the psychiatric symptoms. The first-line approach is typically a course of antibiotics to clear the underlying strep infection. For many children, this alone leads to noticeable improvement.
When antibiotics aren’t enough and a child remains significantly impaired, doctors may consider immune-modulating treatments. A randomized, placebo-controlled trial found that intravenous immunoglobulin (a therapy that helps recalibrate the immune system) produced prolonged and significant improvement in OCD symptoms, anxiety, depression, emotional instability, and overall functioning compared to placebo. Those improvements were still evident at one-year follow-up. Steroid treatment is another option that can help reduce the immune system’s attack on the brain.
Guidelines from the American Academy of Pediatrics recommend that children with PANDAS remain on preventive antibiotics until five years after their last episode, or until age 21, whichever is longer. This extended timeline reflects how vulnerable these children can be to symptom flares with each new strep exposure.
Long-Term Outlook
Early treatment matters significantly. When caught and treated early, PANDAS can go into full remission, with children returning to their baseline behavior and functioning. Left untreated, the condition can cause persistent brain inflammation and ongoing neuropsychiatric symptoms that become harder to reverse over time. The pattern many families experience is one of flare-ups tied to new infections, with each untreated episode potentially leaving behind more residual symptoms.
The fact that immune-based therapies work, that symptoms track with infections, and that antibodies cross-react with brain tissue all point strongly toward an autoimmune process. Whether the broader medical establishment will eventually formalize PANDAS with its own diagnostic criteria in the DSM or ICD remains an open question, but the autoimmune framework is the foundation of how the condition is currently understood and treated.